---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-016947"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:56:32.021605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# TransCode shareholders approve warrant adjustments and share issuance at special meeting

## Summary
- Proposal One approved: full issuance of shares upon exercise of Series C and D warrants with floor price of $2.4882.
- Proposal Two approved: adjournment if needed to solicit more votes; not used as Proposal One passed.
- Vote on Proposal One: 130,226 for, 51,288 against, 8,722 abstained; 190,236 shares present (quorum).
- Total shares entitled to vote: 523,261; no broker non-votes on either proposal.

## SEC filing metadata
- accession: 0001104659-25-016947
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/0001104659-25-016947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/tm257516d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-016947
- JSON: https://secwatch.observer/filing/0001104659-25-016947.json
- Plain text: https://secwatch.observer/filing/0001104659-25-016947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.